Back

StatPearls, LLC

  • Autoantibodies
  • Epidermolysis Bullosa Acquisita

Epidermolysis Bullosa Acquisita

Epidermolysis bullosa acquisita (EBA) is a rare, chronic autoimmune blistering disease that affects both the skin and mucous membranes. This condition arises due to autoantibodies targeting type VII collagen a crucial component of anchoring fibrils within the dermal-epidermal junction. Although EBA can manifest in various phenotypes clinically, the classical mechanobullous and inflammatory forms are the most common presentations. This activity offers insights into the underlying pathogenesis of EBA, involving the production of autoantibodies targeting type VII collagen, which lead to epidermal detachment and the distinctive clinical features observed in EBA. This activity comprehensively reviews the epidemiology, diagnostic approaches, differential diagnosis, current treatment options, and challenges clinicians face in managing EBA. This course assists interprofessional healthcare team members enhance their competence to make well-informed decisions when caring for patients with EBA.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 1.5 creditsAMA PRA Category 1 Credit™Up to 1.5 creditsNursingUp to 1.5 creditsPharmacyUp to 1.5 credits

MOC types

ABS — Accredited CMEUp to 1.5 pointsABPATH — Lifelong LearningUp to 1.5 pointsABTS — Accredited CMEUp to 1.5 pointsABIM — Medical KnowledgeUp to 1.5 pointsABS — Self-AssessmentUp to 1.5 pointsABP — Lifelong Learning and Self-AssessmentUp to 1.5 pointsABTS — Self-AssessmentUp to 1.5 points

FDA REMS

No

Qualifies for MIPS

No

Pricing

Fee varies

This provider typically $49–98

See fees on statpearls.com

Listed by the provider

  • Article / monograph / reference
  • Credit · Up to 1.5 credits
  • MOC · Up to 1.5 points
  • Fee varies · this provider typically $49–98
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Sep 1, 2029 3 years left